- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Buzz
- Twitter: KH
- Twitter: $KH
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
KH Market Currents
more »
-
Thursday 4:11 PM China Kanghui Holdings (KH): Q1 EPS of $0.20 beats by $0.01. Revenue of $13.1M (+21.6% Y/Y) beats by $0.35M. (PR)
Comment![Earnings, Healthcare]
KH in Focus
more »
KH Related Articles
more »
KH News
more »
-
at MarketWatch.com (Jun 1, 2011)
KH Press Releases and Filings
more »
-
PR Newswire (Thu, 4:05PM)
-
PR Newswire (May 8, 2012)
-
PR Newswire (Apr 30, 2012)
-
PR Newswire (Mar 19, 2012)
-
PR Newswire (Mar 12, 2012)
KH Latest Transcript
more »
Currently, there are no transcripts for KH.
KH Cramer
more »
Currently, there are no Cramer articles on KH.
KH Instablog posts
more »
KH vs. ETF Alternatives
Company Description
We are a leading domestic developer, manufacturer and marketer of orthopedic implants in China measured by 2009 sales. We believe our “Kanghui” and “Libeier” brands are two of the most recognized orthopedic implants brands among hospitals and surgeons in China. We are also one of the first... More
